Developers working on methicillin-resistant staphylococcus aureus (MRSA) treatments market are expected to invest resources into research and development activities, for the generation of new product ...

Antimicrobial resistance (AMR) is an increasingly dangerous problem affecting global health. In 2019 alone, methicillin-resistant Staphylococcus aureus (MRSA) accounted for more than 100,000 global ...

YONKERS, N.Y., Feb. 24, 2020 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX), a clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs), ...

As mentioned earlier, there is an urgent need for the development of novel antibiotics targeting S. aureus. Fortunately, a number of new agents active against MRSA and other Gram-positive pathogens ...

Mathematical modeling suggests that the rate at which a patient's immune system clears slow-growing variants of methicillin-resistant Staphylococcus aureus (MRSA) bacteria is a key determinant of ...

Methicillin-resistant Staphylococcus aureus (MRSA) is a type of bacteria that causes an infection that may be resistant to many antibiotics. There are precautions you can take to avoid contracting ...

Methicillin-resistant Staphylococcus aureus (MRSA) is a serious bacterial infection that is resistant to most antibiotic treatments. Healing is possible but severe infections may become chronic or ...

Methicillin-resistant Staphylococcus epidermidis (MRSE) is a drug-resistant form of staph bacteria. MRSE infections may be difficult to treat due to their resistance to methicillin and other common ...